Pulmonary Hypertension Drugs

Global and China Pulmonary Hypertension Drugs Market Research by Company, Type & Application 2013-2025

Report ID: HeyReport 39192 | Number of pages: 69 | Publish Date: Sep 2019 | Category: Lifesciences and Healthcare 
Summary

Market Segment as follows:
By Type
    Prostacyclin and prostacyclin analogs 
    Endothelin receptor antagonists (ERAs) 
    Phosphodiesterase-5 (PDE-5) inhibitors 
    Soluble guanylate cyclase (sGC) stimulators
By Application
    Early-stage Drug Candidates (Phase I & Phase II)
    Late-stage Drug Candidates (Phase III & Registration Phase)
By Company
    Bayer 
    GSK 
    Arena 
    Actelion 
    Pfizer 
    United Therapeutics 
    Gilead Sciences 
    Lung Biotechnology PBC
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Download Sample 
Table of Content
1 Market Overview
    1.1 Market Segment Overview
        1.1.1 Product Definition
        1.1.2 Market by Type
            1.1.2.1 Prostacyclin and prostacyclin analogs 
            1.1.2.2 Endothelin receptor antagonists (ERAs) 
            1.1.2.3 Phosphodiesterase-5 (PDE-5) inhibitors 
            1.1.2.4 Soluble guanylate cyclase (sGC) stimulators
        1.1.3 Market by Application
            1.1.3.1 Early-stage Drug Candidates (Phase I & Phase II)
            1.1.3.2 Late-stage Drug Candidates (Phase III & Registration Phase)
    1.2 Global and China Market Size
        1.2.1 Global Overview
        1.2.2 China Overview
2 Global and China Market by Company
    2.1 Global
        2.1.1 Global Sales by Company
        2.1.2 Global Price by Company
    2.2 China
        2.2.1 China Sales by Company
        2.2.2 China Price by Company
3 Global and China Market by Type
    3.1 Global
        3.1.1 Global Sales by Type
        3.1.2 Global Price by Type
    3.2 China
        3.2.1 China Sales by Type
        3.2.2 China Price by Type
4 Global and China Market by Application
    4.1 Global
        4.1.1 Global Sales by Application
        4.1.2 Global Price by Application
    4.2 China
        4.2.1 China Sales by Application
        4.2.2 China Price by Application
5 China Trade
    5.1 Export
    5.2 Import
6 Key Manufacturers
    6.1 Bayer 
        6.1.1 Company Information
        6.1.2 Product Specifications
        6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    6.2 GSK 
    6.3 Arena 
    6.4 Actelion 
    6.5 Pfizer 
    6.6 United Therapeutics 
    6.7 Gilead Sciences 
    6.8 Lung Biotechnology PBC
7 Industry Upstream
    7.1 Industry Chain
    7.2 Raw Materials
8 Market Environment
    8.1 SWOT
    8.2 Porter's Five Forces
9 Conclusion
Figure Prostacyclin and prostacyclin analogs  Market Size and CAGR 2013-2018 (Million USD)
Figure Prostacyclin and prostacyclin analogs  Market Size and CAGR 2013-2018 (Volume)
Figure Prostacyclin and prostacyclin analogs  Market Forecast and CAGR 2019-2025 (Million USD)
Figure Prostacyclin and prostacyclin analogs  Market Forecast and CAGR 2019-2025 (Volume)
Figure Endothelin receptor antagonists (ERAs)  Market Size and CAGR 2013-2018 (Million USD)
Figure Endothelin receptor antagonists (ERAs)  Market Size and CAGR 2013-2018 (Volume)
Figure Endothelin receptor antagonists (ERAs)  Market Forecast and CAGR 2019-2025 (Million USD)
Figure Endothelin receptor antagonists (ERAs)  Market Forecast and CAGR 2019-2025 (Volume)
Figure Phosphodiesterase-5 (PDE-5) inhibitors  Market Size and CAGR 2013-2018 (Million USD)
Figure Phosphodiesterase-5 (PDE-5) inhibitors  Market Size and CAGR 2013-2018 (Volume)
Figure Phosphodiesterase-5 (PDE-5) inhibitors  Market Forecast and CAGR 2019-2025 (Million USD)
Figure Phosphodiesterase-5 (PDE-5) inhibitors  Market Forecast and CAGR 2019-2025 (Volume)
Figure Soluble guanylate cyclase (sGC) stimulators Market Size and CAGR 2013-2018 (Million USD)
Figure Soluble guanylate cyclase (sGC) stimulators Market Size and CAGR 2013-2018 (Volume)
Figure Soluble guanylate cyclase (sGC) stimulators Market Forecast and CAGR 2019-2025 (Million USD)
Figure Soluble guanylate cyclase (sGC) stimulators Market Forecast and CAGR 2019-2025 (Volume)
Figure Early-stage Drug Candidates (Phase I & Phase II) Market Size and CAGR 2013-2018 (Million USD)
Figure Early-stage Drug Candidates (Phase I & Phase II) Market Size and CAGR 2013-2018 (Volume)
Figure Early-stage Drug Candidates (Phase I & Phase II) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Early-stage Drug Candidates (Phase I & Phase II) Market Forecast and CAGR 2019-2025 (Volume)
Figure Late-stage Drug Candidates (Phase III & Registration Phase) Market Size and CAGR 2013-2018 (Million USD)
Figure Late-stage Drug Candidates (Phase III & Registration Phase) Market Size and CAGR 2013-2018 (Volume)
Figure Late-stage Drug Candidates (Phase III & Registration Phase) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Late-stage Drug Candidates (Phase III & Registration Phase) Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Pulmonary Hypertension Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Global Pulmonary Hypertension Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Global Pulmonary Hypertension Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Pulmonary Hypertension Drugs Market Forecast and CAGR 2019-2025 (Volume)
Figure China Pulmonary Hypertension Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure China Pulmonary Hypertension Drugs Market Size and CAGR 2013-2017 (Volume)
Figure China Pulmonary Hypertension Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Pulmonary Hypertension Drugs Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Pulmonary Hypertension Drugs SWOT List
Figure Pulmonary Hypertension Drugs Porter's Five Forces